Table 1 Cases reported in literature showing the e6a2 transcript

CP - CML

M/41

BMT

Hochhaus et al. [2]

CP - CML

M/50

IFN-Ara C-- > BMT

Dupont et al. [30]

BC - CML

M/65

Imatinib

Schultheis et al. [6]

CP - CML

M/76

IFN

Colla et al. [31]

CML secondary to CMML

F/64

t(11;16)

Imatinib

Hayette et al. [32]

CP - CML

M/37

e1a2

Imatinib

Roti et al. [16]

Acute basophilic leukemia

M/71

Imatinib-Dauno-Ara C

Gregoire et al. [33]

ALL

F/29

G MALL 7/03-Imatinib-- > BMT

Burmeister et al. [34]

CP - CML

M/43

Imatinib

Breccia et al. [35]

AML

F/53

Imatinib-Ida-Ara C

-- > BMT-Dasatinib

Ritchie et al. [22]

AML (M7)

F/53

del(18)(p10)

Imatinib-Ida-Ara C

-- > Dasatinib-BMT

Corm et al. [23]

CP - CML

M/48

Imatinib-- > Dasatinib

Schnittger et al. [36]

CP - CML

M/48

t(7;9), ins(22;9)

Imatinib-- > BMT

Vefring et al. [17]

AP - CML

M/42

Imatinib

-- > BMT-Dasatinib

Vefring et al. [17]

CP - CML

M/67

Imatinib

Popovici et al. [26]

CP - CML

F/18

Imatinib

Torres et al. [37]

AP - CML

M/57

trisomy 8

Imatinib

Beel et al. [18]

CP - CML

M/36

e1a2

Imatinib-Nilotinib

-- > BMT

Langabeer et al. [15]

AP - CML

M/51

Imatinib-- > BMT

Rohon et al. [19]

BC – CML

M/48

Dasatinib

Zagaria et al. [14]

AML (M4)

F/55

Mitox-Ara C-Imatinib

-- > BMT-Dasatinib-DLI

Harada et al. [21]

BC - CML

F/48

trisomy and tetrasomy 8

Dauno-Ara c-Imatinib

-- > BMT

Crampe et al. [20]

AML secondary to CMML

M/58

DNMT3A RUNX1 SUZ12

3 + 7-Dasatinib-Nilotinib

Yao et al. [25]

AML secondary to myelofibrosis

M/80

JAK2-V617F

Hydroxyurea-valproic acid

Dasatinib-Imatinib

Brattas et al. [38]